Loading organizations...

§ Private Profile · New York City, NY, USA
Biopharmaceutical company developing oral NLRP3 antagonist therapeutics.
Olatec Therapeutics has raised $40.0M across 1 funding round.
Olatec Therapeutics has raised $40.0M in total across 1 funding round.
Olatec Therapeutics has raised $40.0M in total across 1 funding round.
Olatec Therapeutics's investors include Don Sanders, Gregory Kennedy.
Olatec Therapeutics has raised $40.0M across 1 funding round. Most recently, it raised $40.0M Series A in February 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 23, 2023 | $40M Series A | DON Sanders | Gregory Kennedy | Announced |